Sign in

CIK 0001506251

  • Non-accelerated filer
  • Smaller reporting company

Citius Pharmaceuticals, Inc.

Sign in to watch
Ticker
CTXR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
NV
Entity type
Operating
EIN
273425913
Phone
+1 908-967-6676
Business address
11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
Former names
Trail One, Inc., TrailOne, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-11-07 Webb Carol Director Grant or award · Stock Option (Right to Purchase Common Stock) +125,000 125,000
2024-03-04 Webb Carol Director Exercise or conversion +12,071 $0.02 $181 12,071
2024-03-04 Webb Carol Director Shares withheld for taxes −236 $0.77 $181 11,835
2024-03-04 Webb Carol Director Exercise or conversion · Stock Option (Right to Purchase Common Stock) −12,071 0
2023-10-10 Webb Carol Director Grant or award · Options to Purchase Common Stock +75,000 75,000
2022-10-04 Webb Carol Director Grant or award · Options to Purchase Common Stock +75,000 75,000
2021-10-11 Webb Carol Director Grant or award · Options to Purchase Common Stock +75,000 75,000
2021-07-22 Webb Carol Director Grant or award · Options to Purchase Common Stock +15,000 15,000
2021-02-16 Webb Carol Director Grant or award · Options to Purchase Common Stock +25,000 25,000
2020-10-06 Webb Carol Director Grant or award · Options to Purchase Common Stock +35,000 35,000
2020-07-07 Webb Carol Director Grant or award · Options to Purchase Common Stock +25,000 25,000
2019-10-08 Webb Carol Director Grant or award · Options to Purchase Common Stock +25,000 25,000
2018-09-04 Webb Carol Director Grant or award · Options to Purchase Common Stock +15,000 15,000
2017-09-15 Webb Carol Director Grant or award · Options to Purchase Common Stock +10,000 10,000
2016-06-23 Webb Carol Director Grant or award · Options to Purchase Common Stock +200,000 $0.80 $160K 200,000

Page 1 of 1 · 15 trades